Table 2.
Time Point | Medicaments | Low | Low to Moderate | Moderate | High |
---|---|---|---|---|---|
1 day | CH (n=8) | 6(75.0%) | 2(25.0%) | 0 | 0 |
2% CHX (n=8) | 5(62.5%) | 3(37.5%) | 0 | 0 | |
Nanosilver (n=8) | 1(12.5%) | 1(12.5%) | 3(37.5%) | 3(37.5%) | |
Control (n=3) | 0 | 0 | 0 | 3(100%) | |
3 days | CH (n=8) | 5 (62.5%) | 2(25.0%) | 1(12.5%) | 0 |
2% CHX (n=8) | 8 (100%) | 0 | 0 | 0 | |
Nanosilver (n=8) | 1 (12.5%) | 1(12.5%) | 2(25.0%) | 4(50.0%) | |
Control (n=3) | 0 | 0 | 1(33.3%) | 2(67.7%) | |
7 days | CH (n=8) | 8(100%) | 0 | 0 | 0 |
2% CHX (n=8) | 8(100%) | 0 | 0 | 0 | |
Nanosilver (n=8) | 0 | 0 | 7(87.5%) | 1(12.5%) | |
Control (n=3) | 0 | 0 | 0 | 3(100%) |